Drawbridge's NanoDrop Secures FDA 510(k) Clearance for Novel Home Blood Sampling Device

Drawbridge Health, a healthcare technology company focused on innovating the blood draw process, has announced that its NanoDrop at-home blood sampling device has received U.S. Food and Drug Administration (FDA) clearance for Over-the-Counter use.

This unique device features dual nano-lancet technology, which complements the already FDA-cleared OneDraw Collection System, and simplifies blood sampling for monitoring glucose levels in diabetic individuals.

NanoDrop is designed as a user-friendly lancet, allowing individuals to obtain capillary whole-blood samples with minimal discomfort through a simple button press.

Its advanced technology not only streamlines at-home health monitoring but also enhances accessibility for healthcare professionals and consumers alike.

The FDA clearance opens doors for large-scale clinical trials involving hard-to-reach participants and facilitates remote monitoring in healthcare settings.

Advancements in small sample capillary blood testing promise greater convenience and compliance in managing diseases like diabetes, metabolic disorders, and infectious diseases.

Anticipates integrating NanoDrop into Thorne's at-home testing kits to provide customers with personalized health data, thus revolutionizing the user experience and expanding accessibility in product development.

The FDA clearance marks a significant milestone in advancing healthcare technology, promising greater convenience, accessibility, and effectiveness in at-home blood sampling and monitoring.

Source: https://www.prnewswire.com/news-releases/drawbridge-secures-fda-510k-clearance-for-at-home-blood-sampling-device-nanodrop-302105547.html